Company: GANX
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001558370-25-011220
Chunk: 14

Company: Gain Therapeutics, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part II, Item 4
Chunk 14
---
Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Insider Trading Arrangements and Policies

During the quarter ended June 30, 2025, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408, that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).